Ho, Tony W.,Kopen, Gene C.,Righter, William F.,Rutkowski, J. Lynn,Herring, W. Joseph,Ragaglia, Vanessa,Wagner, Joseph
申请号：
AU2009208096
公开号：
AU2009208096B2
申请日:
2009.08.11
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2009208096B220130124.pdf#####ABSTRACT Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase. In another embodiment, committed progenitor cells are made by selecting from a cultured source of a cell population which co-expresses CD49c and CD90 and modifying the cell population. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition and to formulate pharmaceutical compositions. In a further embodiment, a substantially homogenous populaton of cells which co-express CD49c, CD90 and at least one cardiac-related transcription factor is made and can be used to treat a human suffering from a cardiac condition.
